These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31980310)

  • 41. Re: Giorgio Gandaglia, Nicola Fossati, Armando Stabile, et al. Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up. Eur Urol 2017;72:289-92: Do the Data Violate Kaplan-Meier Assumptions?
    Mouracade P
    Eur Urol; 2017 Aug; 72(2):e29-e30. PubMed ID: 28238412
    [No Abstract]   [Full Text] [Related]  

  • 42. Re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol 2019;75:319-28.
    Zaorsky NG; Spratt DE; Blanchard P
    Eur Urol; 2019 Apr; 75(4):e96-e97. PubMed ID: 30473434
    [No Abstract]   [Full Text] [Related]  

  • 43. Reply to Francesco Montorsi, Nicola Fossati, Carlo A. Bravi, Giorgio Gandaglia, Nazareno Suardi, and Alberto Briganti's Letter to the Editor re: Sophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy. Eur Urol 2021;79:537-44. Surgical Treatment of Local Recurrence Following Radical Prostatectomy: Reality or Illusion?
    Knipper S; Maurer T
    Eur Urol; 2021 May; 79(5):e134. PubMed ID: 33579574
    [No Abstract]   [Full Text] [Related]  

  • 44. Re: Byron H. Lee, Adam S. Kibel, Jay P. Ciezki, et al. Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence. Eur Urol 2015;67:204-9.
    Lu K
    Eur Urol; 2015 Sep; 68(3):e61-2. PubMed ID: 25913064
    [No Abstract]   [Full Text] [Related]  

  • 45. Reply to Pim J. van Leeuwen and Henk G. van der Poel's Letter to the Editor re: Karim A. Touijer, Robert J. Karnes, Niccolo Passoni, et al. Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies. Eur Urol 2018;73:890-6.
    Touijer K
    Eur Urol; 2018 Jul; 74(1):e18-e19. PubMed ID: 29691082
    [No Abstract]   [Full Text] [Related]  

  • 46. Re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019;75:552-5.
    Froehner M; Thomas C
    Eur Urol; 2019 Sep; 76(3):e75. PubMed ID: 31130432
    [No Abstract]   [Full Text] [Related]  

  • 47. Re: Felix K.-H. Chun, Markus Graefen, Alberto Briganti, Andrea Gallina, Julia Hopp, Michael W. Kattan, Hartwig Huland and Pierre I. Karakiewicz. Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network. Eur Urol 2007;51:1236-43.
    Stephan C; Meyer HA; Cammann H; Lein M; Loening SA; Jung K
    Eur Urol; 2007 May; 51(5):1446-7; author reply 1448. PubMed ID: 17141943
    [No Abstract]   [Full Text] [Related]  

  • 48. Re: Michael L. Eisenberg, Benjamin J. Davies, Matthew R. Cooperberg, et al. Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy. Eur Urol 2010;57:622-30.
    Ost P; Bossi A; De Meerleer G
    Eur Urol; 2010 Sep; 58(3):e33; author reply e34-5. PubMed ID: 20537787
    [No Abstract]   [Full Text] [Related]  

  • 49. Reply to Pascal Mouracade's Letter to the Editor re: Giorgio Gandaglia, Nicola Fossati, Armando Stabile, et al. Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up. Eur Urol 2017;72:289-92. Do the Data Violate Kaplan-Meier Assumptions?
    Gandaglia G; Fossati N; Montorsi F; Briganti A
    Eur Urol; 2017 Aug; 72(2):e31. PubMed ID: 28214034
    [No Abstract]   [Full Text] [Related]  

  • 50. Reply from Authors re: Matthew T. Gettman. Assessing Work Disability After Radical Prostatectomy. Eur Urol 2016;70:72-3: The Challenge of Assessing Work Disability.
    Plym A; Voss M; Stattin P; Lambe M
    Eur Urol; 2016 Jul; 70(1):73-74. PubMed ID: 26873837
    [No Abstract]   [Full Text] [Related]  

  • 51. Reply to Alba Fiorentino, Angelo Errico, and Marcello Scarcia's Letter to the Editor re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol 2019;75:319-28: Radiation Therapy Versus Radical Prostatectomy: No Way Out Without a Randomized Trial.
    Moschini M; Zaffuto E; Mattei A; Karakiewicz PI; Shariat SF
    Eur Urol; 2019 Apr; 75(4):e95. PubMed ID: 30509762
    [No Abstract]   [Full Text] [Related]  

  • 52. Re: Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy?: L. J. Sokoll, Z. Zhang, D. W. Chan, A. C. Reese, T. J. Bivalacqua, A. W. Partin and P. C. Walsh J Urol 2016;195:330-336.
    Edel A; King CR
    J Urol; 2016 Jul; 196(1):283-4. PubMed ID: 27048826
    [No Abstract]   [Full Text] [Related]  

  • 53. Re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019;75:552-5: Comparing Apples to Oranges: A Self-fulfilling Prophecy?
    Kishan AU; Hall WA; Spratt DE
    Eur Urol; 2019 May; 75(5):e133-e134. PubMed ID: 30670312
    [No Abstract]   [Full Text] [Related]  

  • 54. Re: Martin Spahn, Steven Joniau, Paolo Gontero, et al. Outcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20 ng/ml: a European multi-institutional study of 712 patients. Eur Urol 2010;58:1-7.
    Neulander EZ; Wejsman Z
    Eur Urol; 2010 Sep; 58(3):e36; author reply e37-8. PubMed ID: 20605673
    [No Abstract]   [Full Text] [Related]  

  • 55. Reply to Michael Froehner and Christian Thomas's Letter to the Editor re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019;75:552-5.
    Berg S; Cole A; Trinh QD
    Eur Urol; 2019 Sep; 76(3):e76-e77. PubMed ID: 31174890
    [No Abstract]   [Full Text] [Related]  

  • 56. Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes.
    Preisser F; Chun FKH; Pompe RS; Heinze A; Salomon G; Graefen M; Huland H; Tilki D
    Eur Urol; 2019 Jul; 76(1):106-114. PubMed ID: 30772034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Re: Jim C. Hu, David M. Nanus, Art Sedrakyan. Increase in Prostate Cancer Metastases at Radical Prostatectomy in the United States. Eur Urol 2017;71:147-9.
    Kim JH; Khandwala YS; Chung BI
    Eur Urol; 2017 Aug; 72(2):e41-e42. PubMed ID: 28365161
    [No Abstract]   [Full Text] [Related]  

  • 58. Re: A High Percent Free Prostate Specific Antigen in the Setting of Biochemical Recurrence after Radical Prostatectomy is Associated with Poorer Outcomes: A Validation Study Using Prospectively Collected Biobank SpecimensDixon T. S. Woon, Jaime O. Herrera-Cáceres, Hanan Goldberg, Hina Shiakh, Emily Whelan, Gregory Nason, Khaled Ajib, Guan Hee Tan, Thenappan Chandrasekar, Omar Alhunaidi, Antonio Finelli, Alexandre Zlotta, Alejandro Berlin, Eleftherios Diamantis and Neil Fleshner
    Li N; Sun Y; Li JG; Long H
    J Urol; 2021 Jan; 205(1):277. PubMed ID: 33035146
    [No Abstract]   [Full Text] [Related]  

  • 59. Does seminal vesicle-sparing robotic radical prostatectomy influence postoperative prostate-specific antigen measured with an ultrasensitive immunoassay?
    Burkhardt O; Neuenschwander JE; John H; Randazzo M
    Swiss Med Wkly; 2018 Nov; 148():w14685. PubMed ID: 30474852
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Re: Jim C. Hu, Giorgio Gandaglia, Pierre I. Karakiewicz, et al. Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control. Eur Urol 2014;66:666-72.
    Froehner M; Wirth MP
    Eur Urol; 2014 Nov; 66(5):e85. PubMed ID: 24867149
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.